For decades, beta-blockers have been used widely to treat cardiovascular diseases. Surprisingly, new data show how these inhibitors can also improve immunotherapy against tumors and chronic infections.
References
Zehn, D., Thimme, R., Lugli, E., de Almeida, G. P. & Oxenius, A. Nat. Immunol. 23, 836–847 (2022).
Utzschneider, D. T. et al. J. Exp. Med. 213, 1819–1834 (2016).
McLane, L. M., Abdel-Hakeem, M. S. & Wherry, E. J. Annu. Rev. Immunol. 37, 457–495 (2019).
Globig, A. et al. Nature https://doi.org/10.1038/s41586-023-06568-6 (2023).
Alfei, F. et al. Nature 571, 265–269 (2019).
Khan, O. et al. Nature 571, 211–218 (2019).
Scott, A. C. et al. Nature 571, 270–274 (2019).
Yao, C. et al. Nat. Immunol. 20, 890–901 (2019).
Skaper, S. D. Immunology 151, 1–15 (2017).
Wu, V. H. et al. Nat. Immunol. 24, 1318–1330 (2023).
Nissen, M. D., Sloan, E. K. & Mattarollo, S. R. Cancer Immunol. Res. 6, 98–109 (2018).
Estrada, L. D., Agac, D. & Farrar, J. D. Eur. J. Immunol. 46, 1948–1958 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Berner, J., Zehn, D. An adrenaline kick to exhaust T cells. Nat Immunol 24, 1792–1793 (2023). https://doi.org/10.1038/s41590-023-01650-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-023-01650-7
- Springer Nature America, Inc.